Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 53 articles: HTML format Text format

Single Articles

June 2018
1. QI LN, Xiang BD, Wu FX, Ye JZ, et al
   Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma.
   Cancer Res. 2018 Jun 18. pii: 0008-5472.CAN-17-2459.
   PubMed     Text format     Abstract available
   
   
   
2. 
   Retraction: Identification of Brain-Derived Neurotrophic Factor as a Novel Functional Protein in Hepatocellular Carcinoma.
   Cancer Res. 2018;78:3400.
   PubMed     Text format    
   
   
   
3. 
   Retraction: The Potential Role of Hypoxia Inducible Factor 1alpha in Tumor Progression after Hypoxia and Chemotherapy in Hepatocellular Carcinoma.
   Cancer Res. 2018;78:3399.
   PubMed     Text format    
   
   
   
4. HILL MA, Alexander WB, Guo B, Kato Y, et al
   Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma.
   Cancer Res. 2018 Jun 5. pii: 0008-5472.CAN-17-1123.
   PubMed     Text format     Abstract available
   
   
   May 2018
5. MENG J, Chen S, Han J, Qian B, et al
   Twist1 regulates Vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma.
   Cancer Res. 2018 May 29. pii: 0008-5472.CAN-17-3009.
   PubMed     Text format     Abstract available
   
   
   
6. WEN LZ, Ding K, Wang ZR, Ding CH, et al
   SHP-1 acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
   Cancer Res. 2018 May 18. pii: 0008-5472.CAN-17-3896.
   PubMed     Text format     Abstract available
   
   
   March 2018
7. XU J, Yang Y, Xie R, Liu J, et al
   The NCX1/TRPC6 complex mediates TGFbeta-driven migration and invasion of human hepatocellular carcinoma cells.
   Cancer Res. 2018 Mar 2. pii: 0008-5472.CAN-17-2061.
   PubMed     Text format     Abstract available
   
   
   February 2018
8. CAI Z, Qian ZY, Jiang H, Ma N, et al
   hPCL3s promotes hepatocellular carcinoma metastasis by activating beta-catenin signaling.
   Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-0028.
   PubMed     Text format     Abstract available
   
   
   
9. CHENG BY, Lau EY, Leung HW, Leung CO, et al
   IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma.
   Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-2445.
   PubMed     Text format     Abstract available
   
   
   
10. ZHANG YL, Li Q, Yang XM, Fang F, et al
    SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-2867.
    PubMed     Text format     Abstract available
    
    
    January 2018
11. RHEE H, Kim HY, Choi JH, Woo HG, et al
    Keratin 19 expression in hepatocellular carcinoma is regulated by fibroblast-derived HGF via a MET-ERK1/2-AP1 and SP1 axis.
    Cancer Res. 2018 Jan 23. pii: 0008-5472.CAN-17-0988.
    PubMed     Text format     Abstract available
    
    
    December 2017
12. JOSHI JJ, Coffey H, Corcoran E, Tsai J, et al
    H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.
    Cancer Res. 2017;77:6999-7013.
    PubMed     Text format     Abstract available
    
    
    November 2017
13. YAN Q, Jiang L, Liu M, Yu D, et al
    ANGPTL1 Interacts with Integrin alpha1beta1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.
    Cancer Res. 2017;77:5831-5845.
    PubMed     Text format     Abstract available
    
    
    
14. D'COSTA Z, Jones K, Azad A, van Stiphout R, et al
    Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer.
    Cancer Res. 2017;77:5952-5962.
    PubMed     Text format     Abstract available
    
    
    October 2017
15. ZHANG CZ, Chen SL, Wang CH, He YF, et al
    CBX8 exhibits oncogenic activity via AKT/beta-Catenin activation in hepatocellular carcinoma.
    Cancer Res. 2017 Oct 24. pii: canres.0700.2017.
    PubMed     Text format     Abstract available
    
    
    
16. TSCHIDA BR, Temiz NA, Kuka TP, Lee LA, et al
    Sleeping Beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumor.
    Cancer Res. 2017 Oct 9. pii: canres.2281.2017.
    PubMed     Text format     Abstract available
    
    
    September 2017
17. MATSUMOTO T, Takai A, Eso Y, Kinoshita K, et al
    Proliferating EpCAM-positive ductal cells in the inflamed liver give rise to hepatocellular carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1800.2017.
    PubMed     Text format     Abstract available
    
    
    
18. TENG Y, Zhao H, Gao L, Zhang W, et al
    FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4-GSK3beta-Nrf2 signaling.
    Cancer Res. 2017 Sep 26. pii: canres.2039.2017.
    PubMed     Text format     Abstract available
    
    
    
19. YAN X, Zhang D, Wu W, Wu S, et al
    Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a.
    Cancer Res. 2017 Sep 25. pii: canres.1915.2017.
    PubMed     Text format     Abstract available
    
    
    August 2017
20. MENDEZ-LUCAS A, Li X, Hu J, Che L, et al
    Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.
    Cancer Res. 2017;77:4355-4364.
    PubMed     Text format     Abstract available
    
    
    
21. YE J, Li TS, Xu G, Zhao YM, et al
    JCAD Promotes Progression of Non-alcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
    Cancer Res. 2017 Aug 3. pii: canres.0229.2017.
    PubMed     Text format     Abstract available
    
    
    
22. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Intestine-Specific Homeobox Gene ISX Integrates IL6 Signaling, Tryptophan Catabolism, and Immune Suppression.
    Cancer Res. 2017;77:4065-4077.
    PubMed     Text format     Abstract available
    
    
    July 2017
23. TILL J, Yoon C, Kim BJ, Roby KC, et al
    Oncogenic KRAS and p53 loss drive gastric tumorigenesis in mice that can be attenuated by E-cadherin expression.
    Cancer Res. 2017 Jul 31. pii: canres.0061.2017.
    PubMed     Text format     Abstract available
    
    
    
24. NG KY, Chan LH, Chai S, Tong M, et al
    TP53INP1 down-regulation activates a p73-dependent DUSP10/ERK signaling pathway to promote metastasis of hepatocellular carcinoma.
    Cancer Res. 2017 Jul 3. pii: canres.3456.2016.
    PubMed     Text format     Abstract available
    
    
    
25. BARBAZAN J, Alonso-Alconada L, Elkhatib N, Geraldo S, et al
    Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits.
    Cancer Res. 2017;77:3431-3441.
    PubMed     Text format     Abstract available
    
    
    June 2017
26. NGO HKC, Kim DH, Cha YN, Na HK, et al
    Nrf2 mutagenic activation drives hepatocarcinogenesis.
    Cancer Res. 2017 Jun 27. pii: canres.3538.2016.
    PubMed     Text format     Abstract available
    
    
    
27. AKIEL M, Guo C, Li X, Rajasekaran D, et al
    IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
    Cancer Res. 2017 Jun 15. pii: canres.2885.2016.
    PubMed     Text format     Abstract available
    
    
    April 2017
28. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Text format     Abstract available
    
    
    
29. JARIWALA N, Rajasekaran D, Mendoza RG, Shen XN, et al
    Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Cancer Res. 2017 Apr 20. pii: canres.0298.2017.
    PubMed     Text format     Abstract available
    
    
    
30. YUE F, Li W, Zou J, Jiang X, et al
    Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma by activating MAP1S-mediated autophagy.
    Cancer Res. 2017 Apr 6. pii: canres.3462.2016.
    PubMed     Text format     Abstract available
    
    
    March 2017
31. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    PubMed     Text format     Abstract available
    
    
    February 2017
32. LIN DC, Mayakonda A, Dinh HQ, Huang P, et al
    Genomic and epigenomic heterogeneity of hepatocellular carcinoma.
    Cancer Res. 2017 Feb 20. pii: canres.2822.2016.
    PubMed     Text format     Abstract available
    
    
    
33. YAN C, Yang Q, Gong Z
    Tumor-associated neutrophils and macrophages promote gender disparity in hepatocellular carcinoma in zebrafish.
    Cancer Res. 2017 Feb 15. pii: canres.2200.2016.
    PubMed     Text format     Abstract available
    
    
    January 2017
34. LUO C, Cheng Y, Liu Y, Chen L, et al
    SRSF2 regulates alternative splicing to drive hepatocellular carcinoma development.
    Cancer Res. 2017 Jan 12. pii: canres.1919.2016.
    PubMed     Text format     Abstract available
    
    
    December 2016
35. MALAKAR P, Shilo A, Mogilavsky A, Stein I, et al
    Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation.
    Cancer Res. 2016 Dec 19. pii: canres.1508.2016.
    PubMed     Text format     Abstract available
    
    
    November 2016
36. CHEN G, Nakamura I, Dhanasekaran R, Iguchi E, et al
    Transcriptional induction of Periostin by a Sulfatase 2-TGFbeta1-SMAD signaling axis mediates tumor angiogenesis in hepatocellular carcinoma.
    Cancer Res. 2016 Nov 21. pii: canres.2556.2015.
    PubMed     Text format     Abstract available
    
    
    October 2016
37. MAO X, Wong SY, Tse EY, Ko FC, et al
    Mechanisms through which hypoxia-induced caveolin-1 drives tumorigenesis and metastasis in hepatocellular carcinoma.
    Cancer Res. 2016 Oct 26. pii: canres.1031.2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
38. TANG B, Qi G, Tang F, Yuan S, et al
    Aberrant JMJD3 expression upregulates Slug to promote migration, invasion and stem cell-like behaviors in hepatocellular carcinoma.
    Cancer Res. 2016 Sep 20. pii: canres.3029.2015.
    PubMed     Text format     Abstract available
    
    
    
39. ALLAIN C, Angenard G, Clement B, Coulouarn C, et al
    Integrative genomic analysis identifies the core transcriptional hallmarks of human hepatocellular carcinoma.
    Cancer Res. 2016 Sep 12. pii: canres.1559.2016.
    PubMed     Text format     Abstract available
    
    
    
40. ZHANG L, Ge C, Zhao F, Zhang Y, et al
    NRBP2 overexpression increases the chemosensitivity of hepatocellular carcinoma cells via Akt signaling.
    Cancer Res. 2016 Sep 7. pii: canres.0937.2016.
    PubMed     Text format     Abstract available
    
    
    August 2016
41. WOLF B, Krieg K, Falk C, Breuhahn K, et al
    Inducing differentiation of premalignant hepatic cells as a novel therapeutic strategy in hepatocarcinoma.
    Cancer Res. 2016 Aug 3. pii: canres.3453.2015.
    PubMed     Text format     Abstract available
    
    
    June 2016
42. LI K, Shen B, Cheng X, Ma D, et al
    Phenotypic and signaling consequences of a novel aberrantly spliced transcript FGF receptor-3 in hepatocellular carcinoma.
    Cancer Res. 2016 Jun 7. pii: canres.3385.2015.
    PubMed     Text format     Abstract available
    
    
    May 2016
43. RIZZA S, Montagna C, Cardaci S, Maiani E, et al
    <i>S</i>-nitrosylation of the mitochondrial chaperone TRAP1 sensitizes hepatocellular carcinoma cells to inhibitors of succinate dehydrogenase.
    Cancer Res. 2016 May 23. pii: canres.2637.2015.
    PubMed     Text format     Abstract available
    
    
    April 2016
44. HIRATA H, Sugimachi K, Komatsu H, Ueda M, et al
    Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Cancer Res. 2016 Apr 6. pii: canres.2601.2015.
    PubMed     Text format     Abstract available
    
    
    March 2016
45. LIN D, Lei L, Liu Y, Zhang Y, et al
    Membrane IL1alpha Inhibits the Development of Hepatocellular Carcinoma via Promoting T- and NK-cell Activation.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available
    
    
    
46. LU Y, Li N, Gao L, Xu YJ, et al
    Acetylcarnitine is a candidate diagnostic and prognostic biomarker of hepatocellular carcinoma.
    Cancer Res. 2016 Mar 14. pii: canres.3199.2015.
    PubMed     Text format     Abstract available
    
    
    
47. LIU L, Zhao X, Zhao L, Li J, et al
    Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth.
    Cancer Res. 2016;76:1260-72.
    PubMed     Text format     Abstract available
    
    
    February 2016
48. MARKOWITZ GJ, Yang P, Fu J, Michelotti GA, et al
    Inflammation-dependent IL-18 signaling restricts hepatocellular carcinoma growth by enhancing the accumulation and activity of tumor-infiltrating lymphocytes.
    Cancer Res. 2016 Feb 18. pii: canres.1548.2015.
    PubMed     Text format     Abstract available
    
    
    
49. YE LY, Chen W, Bai XL, Xu XY, et al
    Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available
    
    
    January 2016
50. BORGHESAN M, Fusilli C, Rappa F, Panebianco C, et al
    DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available
    
    
    
51. TANEI T, Leonard F, Liu X, Alexander JF, et al
    Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.
    Cancer Res. 2016;76:429-39.
    PubMed     Text format     Abstract available
    
    
    December 2015
52. CHEN HN, Yuan K, Xie N, Wang K, et al
    PDLIM1 stabilizes the E-cadherin/beta-catenin complex to prevent epithelial-mesenchymal transition and metastatic potential of colorectal cancer cells.
    Cancer Res. 2015 Dec 23. pii: canres.1962.2015.
    PubMed     Text format     Abstract available
    
    
    April 2015
53. BONASTRE E, Verdura S, Zondervan I, Facchinetti F, et al
    PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.
    Cancer Res. 2015;75:1287-97.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: